Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002310870 | SCV000319319 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2021-10-15 | criteria provided, single submitter | clinical testing | The p.I574V variant (also known as c.1720A>G), located in coding exon 12 of the FBN2 gene, results from an A to G substitution at nucleotide position 1720. The isoleucine at codon 574 is replaced by valine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV000765802 | SCV000897192 | uncertain significance | Congenital contractural arachnodactyly; Macular degeneration, early-onset | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000810490 | SCV000950693 | benign | Congenital contractural arachnodactyly | 2023-11-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004692879 | SCV005188579 | uncertain significance | not provided | criteria provided, single submitter | not provided |